1.10
price up icon0.92%   0.01
after-market Handel nachbörslich: 1.09 -0.01 -0.91%
loading

Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 1.143
Operating Expenses
2.50%
17.54
17.99 20.35 17.12 20.10
Operating Income/Loss
2.50%
-17.54
-17.99 -20.35 -17.12 -18.96
Nonoperating Income/Loss
348.98%
-0.44
-0.098 -0.052 0.451 1.711
Income/Loss From Continuing Operations Before Tax
0.59%
-17.98
-18.09 -20.40 -16.67 -17.25
Income/Loss From Continuing Operations After Tax
0.59%
-17.98
-18.09 -20.40 -16.67 -17.25
Net Income/Loss
0.59%
-17.98
-18.09 -20.40 -16.67 -17.25
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.34%
44.98
44.83 0.3848 43.70 43.52
Diluted Average Shares
0.34%
44.98
44.83 0.4734 43.70 44.04
Basic Earnings Per Share
0.00%
-0.40
-0.40 -0.46 -0.38 -0.40
Diluted Earnings Per Share
0.00%
-0.40
-0.40 -0.44 -0.38 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):